Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
CA 2467752 A1 · Owner: Ono Pharmaceutical Co. Ltd. · Inventors: Yamamoto, Shingo; Naka, Masao; Takahashi, Kanji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Piperidin-2-one derivative compounds represented by the following general formula (I) and salts thereof: wherein each symbol is as defined in the description. Because of inhibiting the activation of p38MAP kinase the , compounds represented by the general formula (I) are useful in preventing and/or treating various inflammatory diseases rheumatoid arthritis, arthritis , deformans arthritis, osteoporosis, autoimmune diseases infections, sepsis, cachexia, brain infarction Alzheimer~s disease, asthma, chronic obstructive pulmonary disease, reperfusion injury, thrombosis glomerular nephritis, diabetes, host-versus-graft rejection inflammatory colon diseases, Crohn~s , disease ulcerative …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.